Cronos Group Inc. ( CRON) - Key Metrics
CRON Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.12 | $0 | $0.03 | $0.03 |
| 2025Q3 | $0.09 | $0.07 | $0.03 | $0.02 |
| 2025Q2 | $0.09 | -$0.10 | $0.01 | $0 |
| 2025Q1 | $0.11 | $0.02 | -$0.01 | -$0.06 |
CRON Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -135.96 |
| 2025Q3 | ? | 10.26 |
| 2025Q2 | ? | -4.65 |
| 2025Q1 | ? | 22.26 |
CRON Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.92% | ? |
| 2025Q4 | 0.97% | ? |
| 2025Q3 | 0.81% | ? |
| 2025Q2 | -0.14% | ? |
| 2025Q1 | -2.52% | ? |
CRON
Price: $2.78
52 week price:
Payout Ratio Range:
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Canada
Volume: 1.5 million
Market Capitalization: 1.1 billion